Motor Neurone Disease Trial, Recruiting (NCT07091799)

Motor Neurone Disease Trial, Recruiting NCT07091799 Sponsor: University Hospital, Bordeaux Condition: Motor Neurone Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07091799 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Motor Neurone Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with ALS (also known as Lou Gehrig's disease), either as a probable or confirmed diagnosis, based on recognised medical guidelines (called the El Escorial criteria).
You are an adult.
You are covered by a social security or health insurance scheme.
You are able to give your free and informed agreement to take part in writing — or someone else can sign on your behalf if you are physically unable to do so.

Who may not be able to join:

You are currently taking medications that suppress the immune system or corticosteroids (a type of anti-inflammatory medicine).
You are already taking part in another clinical trial that involves an experimental treatment.
You are under a legal protection arrangement such as guardianship or curatorship (a court-appointed arrangement to help manage your affairs).
If you are a healthy volunteer, you may not be able to join if you are a close family member of a patient in the trial (such as a sibling, parent, grandparent, child, or grandchild).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05 57 82 13 70

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07091799

Sponsor: University Hospital, Bordeaux

Phase: Not Applicable

Status: Recruiting

Condition: Motor Neurone Disease

Trial contact: 05 57 82 13 70

More information: https://clinicaltrials.gov/study/NCT07091799

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with ALS (also known as Lou Gehrig's disease), either as a probable or confirmed diagnosis, based on recognised medical guidelines (called the El Escorial criteria).
You are an adult.
You are covered by a social security or health insurance scheme.
You are able to give your free and informed agreement to take part in writing — or someone else can sign on your behalf if you are physically unable to do so.

Who may not be able to join:

You are currently taking medications that suppress the immune system or corticosteroids (a type of anti-inflammatory medicine).
You are already taking part in another clinical trial that involves an experimental treatment.
You are under a legal protection arrangement such as guardianship or curatorship (a court-appointed arrangement to help manage your affairs).
If you are a healthy volunteer, you may not be able to join if you are a close family member of a patient in the trial (such as a sibling, parent, grandparent, child, or grandchild).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Bordeaux

Registry

ClinicalTrials.gov

Start date

15 January 2026

Est. completion

1 January 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Expression of P2X4 receptor

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov